Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Search
Sign in
Sign up
Envista
NVST
Market cap
$3.98B
Overview
Fund Trends
Analyst Outlook
Journalist POV
24.20
USD
+0.97
4.18%
At close
Updated
Jan 14, 4:00 PM EST
Pre-market
After hours
24.24
+0.04
0.17%
1D
5D
1M
3M
6M
YTD
1Y
5Y
10Y
1 day
4.18%
5 days
5.63%
1 month
9.7%
3 months
24.42%
6 months
20.82%
Year to date
11.57%
1 year
28.38%
5 years
-31.23%
10 years
-13.42%
Upgrade to unlock
Positive
Neutral
Negative
Sentiment
3-Months
Positive
Neutral
53.3%
Negative
Positive
Neutral
Negative
Neutral
Seeking Alpha
yesterday
Envista Holdings Corporation (NVST) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Envista Holdings Corporation (NVST) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral
PRNewsWire
6 days ago
Envista Schedules Fourth Quarter 2025 Earnings Call
BREA, Calif., Jan. 8, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2025 on Thursday, February 5, 2026.
Neutral
PRNewsWire
7 days ago
Envista to Present at the 44th Annual J.P. Morgan Healthcare Conference
BREA, Calif., Jan. 7, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will present at the 44th Annual J.P.
Positive
Zacks Investment Research
7 days ago
Here's Why You Should Add NVST Stock to Your Portfolio Right Now
Envista's global expansion, bolt-on acquisitions, and strong balance sheet support growth, even as currency swings pressure sales.
Positive
Zacks Investment Research
15 days ago
NVST vs. SYK: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical - Products sector might want to consider either Envista (NVST) or Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
Neutral
Seeking Alpha
1 month ago
Envista Holdings Corporation (NVST) Presents at Evercore 8th Annual Healthcare Conference Transcript
Envista Holdings Corporation (NVST) Presents at Evercore 8th Annual Healthcare Conference Transcript
Positive
Zacks Investment Research
1 month ago
Here's Why Envista (NVST) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Neutral
PRNewsWire
1 month ago
Envista Announces Participation in 8th Annual Evercore Healthcare Conference
BREA, Calif. , Nov. 25, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the 8th Annual Evercore Healthcare Conference.
Positive
Zacks Investment Research
2 months ago
Envista (NVST) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Neutral
Seeking Alpha
2 months ago
Envista Holdings Corporation (NVST) Q3 2025 Earnings Call Transcript
Envista Holdings Corporation ( NVST ) Q3 2025 Earnings Call October 30, 2025 5:00 PM EDT Company Participants Jim Gustafson - Vice President of Investor Relations Paul Keel - CEO & Director Eric Hammes - Senior VP & CFO Conference Call Participants Allen Lutz - BofA Securities, Research Division Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Michael Cherny - Leerink Partners LLC, Research Division Jeffrey Johnson - Robert W. Baird & Co. Incorporated, Research Division Linda Bolduc - Morgan Stanley, Research Division Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division Steven Valiquette - Mizuho Securities USA LLC, Research Division Michael Sarcone - Jefferies LLC, Research Division Russell Yuen - William Blair & Company L.L.C.
Show more
See News Rankings
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Theme
Close